Agilent Technologies Expands Therapeutic Nucleic Acids Manufacturing Capacity
Agilent Technologies Inc. announced the expansion of its nucleic acid active pharmaceutical ingredient (API) manufacturing facility in Boulder, Colo. Agilent's Nucleic Acids Solutions Division is adding large-scale nucleic acid synthesis, purification and drying capacity that will come on stream by the end of 2008. As a part of this expansion, Agilent has purchased from Dowpharma all of the assets of its Nucleic ... more
CRELUX and ProQinase establish joint crystal-grade kinase protein and structures platform
CRELUX and ProQinase announced that they have entered into a joint agreement to supply customers with crystal-grade protein kinases and readily available kinase complex structures. Under the agreement, CRELUX and ProQinase will establish and continuously expand an off-the-shelf crystal-grade protein kinase portfolio, optimized and quality-controlled for successful crystallization. In addition, the two companies ... more
Top